新闻中心

News Center

Home page

All Categories



Company News

Olanzapine Tablets Passed the Consistency Evaluation of Generic Drugs

Release Time

2022-06-21 16:25

Recently, Olanzhi® Olanzapine Tablets (specification: 5mg*20 tablets, 10mg*20 tablets), which are generally distributed by Shenzhen Foncoo Pharmaceutical Co., Ltd., passed the national generic drug quality and efficacy consistency evaluation. Olanzhi is produced by Dr. Reddy Laboratories Ltd. of India using US cGMP standards, but the price is similar to other olanzapine generics. In 2011, Olanzhi was approved by the US FDA and was the first generic olanzapine drug to be marketed in the United States, and its market share exceeded that of the original olanzapine; in Europe, 1 out of every 2 patients taking olanzapine Oran's. Oranzhi submitted generic drug consistency evaluation data in China in October 2018, and passed the review in early September 2019. So far, in addition to the original research olanzapine in the domestic market, Olanzhi is the only olanzapine tablet certified by the US FDA, EU EMEA, and China's three major systems of consistency evaluation.